This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Opexa Therapeutics Inc (OPXA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 9.91M 23.64M 592.00K 7.11M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 259.99K 1.12M 1.08M 124.77K
Total Current Assets 10.67M 24.77M 1.67M 7.23M
Property, Plant & Equipment, Gross 3.20M 3.01M 2.76M 2.22M
Accumulated Depreciation & Depletion 2.10M 1.72M 1.49M 1.19M
Property, Plant & Equipment, Net 1.10M 1.30M 1.27M 1.03M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 38.94K 177.67K 1.21M 0.00
Total Non-Current Assets 1.14M 1.47M 2.48M 1.03M
Liabilities & Shareholder Equity
Total Assets 11.80M 26.24M 4.15M 8.26M
Accounts Payable 702.49K 696.15K 412.10K 491.31K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 3.13M 3.32M 885.98K 1.07M
Long Term Debt 0.00 0.00 376.76K 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.23M 2.34M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.23M 2.34M 376.76K 0.00
Total Liabilities 4.36M 5.66M 1.26M 1.07M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 7.44M 20.58M 2.88M 7.20M
Common Par 282.35K 275.46K 62.49K 230.49K
Additional Paid In Capital 148.48M 146.57M 112.43M 107.65M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -141.32M -126.27M -109.61M -100.68M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 7.44M 20.58M 3.26M 7.20M
Total Equity 7.44M 20.58M 2.88M 7.20M
Total Liabilities & Stock Equity 11.80M 26.24M 4.15M 8.26M
Total Common Shares Outstanding 3.53M 3.44M 781.17K 720.26K
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 3.48M 1.67M 723.17K 704.14K
Diluted Weighted Shares Outstanding 3.48M 1.67M 723.17K 704.14K
Number of Employees 39 38 26 19
Number of Part-Time Employees 0 0 0 0

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

OPXA Opexa Therapeutics Inc

Chart of OPXA

Analysts Ratings for OPXA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 0
Moderate Buy 1 1 1 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

OPXA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs